The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis.
Critical illness
ICU-AW
ICU-acquired weakness
Intensive care unit
Muscle atrophy
Muscle wasting
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
03 01 2023
03 01 2023
Historique:
received:
29
09
2022
accepted:
23
11
2022
entrez:
3
1
2023
pubmed:
4
1
2023
medline:
6
1
2023
Statut:
epublish
Résumé
Patients with critical illness can lose more than 15% of muscle mass in one week, and this can have long-term detrimental effects. However, there is currently no synthesis of the data of intensive care unit (ICU) muscle wasting studies, so the true mean rate of muscle loss across all studies is unknown. The aim of this project was therefore to systematically synthetise data on the rate of muscle loss and to identify the methods used to measure muscle size and to synthetise data on the prevalence of ICU-acquired weakness in critically ill patients. We conducted a systematic literature search of MEDLINE, PubMed, AMED, BNI, CINAHL, and EMCARE until January 2022 (International Prospective Register of Systematic Reviews [PROSPERO] registration: CRD420222989540. We included studies with at least 20 adult critically ill patients where the investigators measured a muscle mass-related variable at two time points during the ICU stay. We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and assessed the study quality using the Newcastle-Ottawa Scale. Fifty-two studies that included 3251 patients fulfilled the selection criteria. These studies investigated the rate of muscle wasting in 1773 (55%) patients and assessed ICU-acquired muscle weakness in 1478 (45%) patients. The methods used to assess muscle mass were ultrasound in 85% (n = 28/33) of the studies and computed tomography in the rest 15% (n = 5/33). During the first week of critical illness, patients lost every day -1.75% (95% CI -2.05, -1.45) of their rectus femoris thickness or -2.10% (95% CI -3.17, -1.02) of rectus femoris cross-sectional area. The overall prevalence of ICU-acquired weakness was 48% (95% CI 39%, 56%). On average, critically ill patients lose nearly 2% of skeletal muscle per day during the first week of ICU admission.
Sections du résumé
BACKGROUND
Patients with critical illness can lose more than 15% of muscle mass in one week, and this can have long-term detrimental effects. However, there is currently no synthesis of the data of intensive care unit (ICU) muscle wasting studies, so the true mean rate of muscle loss across all studies is unknown. The aim of this project was therefore to systematically synthetise data on the rate of muscle loss and to identify the methods used to measure muscle size and to synthetise data on the prevalence of ICU-acquired weakness in critically ill patients.
METHODS
We conducted a systematic literature search of MEDLINE, PubMed, AMED, BNI, CINAHL, and EMCARE until January 2022 (International Prospective Register of Systematic Reviews [PROSPERO] registration: CRD420222989540. We included studies with at least 20 adult critically ill patients where the investigators measured a muscle mass-related variable at two time points during the ICU stay. We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and assessed the study quality using the Newcastle-Ottawa Scale.
RESULTS
Fifty-two studies that included 3251 patients fulfilled the selection criteria. These studies investigated the rate of muscle wasting in 1773 (55%) patients and assessed ICU-acquired muscle weakness in 1478 (45%) patients. The methods used to assess muscle mass were ultrasound in 85% (n = 28/33) of the studies and computed tomography in the rest 15% (n = 5/33). During the first week of critical illness, patients lost every day -1.75% (95% CI -2.05, -1.45) of their rectus femoris thickness or -2.10% (95% CI -3.17, -1.02) of rectus femoris cross-sectional area. The overall prevalence of ICU-acquired weakness was 48% (95% CI 39%, 56%).
CONCLUSION
On average, critically ill patients lose nearly 2% of skeletal muscle per day during the first week of ICU admission.
Identifiants
pubmed: 36597123
doi: 10.1186/s13054-022-04253-0
pii: 10.1186/s13054-022-04253-0
pmc: PMC9808763
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2Informations de copyright
© 2023. The Author(s).
Références
Crit Care. 2010;14(3):R119
pubmed: 20565863
J Ultrasound Med. 2015 Jul;34(7):1191-200
pubmed: 26112621
J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1321-1335
pubmed: 32677363
Crit Care Med. 2020 Sep;48(9):1327-1333
pubmed: 32706557
Crit Care Med. 2009 Sep;37(9):2632-7
pubmed: 19623045
BMC Anesthesiol. 2018 Dec 27;18(1):205
pubmed: 30591032
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
JPEN J Parenter Enteral Nutr. 2017 Feb;41(2):171-180
pubmed: 26962061
Intensive Care Med. 2020 Jun;46(6):1184-1193
pubmed: 31970446
Physiol Rev. 2015 Jul;95(3):1025-109
pubmed: 26133937
Am J Respir Crit Care Med. 2017 Jan 1;195(1):136-138
pubmed: 28035857
World J Cardiol. 2020 Jul 26;12(7):351-361
pubmed: 32843937
Clin Nutr. 2004 Apr;23(2):273-80
pubmed: 15030968
J Physiol. 2019 Mar;597(5):1259-1270
pubmed: 29968251
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
PLoS One. 2019 Nov 14;14(11):e0224565
pubmed: 31725748
N Engl J Med. 2014 Apr 24;370(17):1626-35
pubmed: 24758618
Indian J Crit Care Med. 2018 Nov;22(11):781-788
pubmed: 30598564
Thorax. 2018 Oct;73(10):926-935
pubmed: 29980655
Am J Respir Crit Care Med. 2008 Aug 1;178(3):261-8
pubmed: 18511703
Rev Bras Ter Intensiva. 2017 Oct-Dec;29(4):466-475
pubmed: 29236843
Trans R Soc Trop Med Hyg. 2019 Nov 1;113(11):706-713
pubmed: 31340037
J Crit Care. 2018 Dec;48:1-8
pubmed: 30118978
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1437-46
pubmed: 25496103
Anesthesiology. 2014 May;120(5):1182-91
pubmed: 24608360
JAMA. 2002 Dec 11;288(22):2859-67
pubmed: 12472328
JPEN J Parenter Enteral Nutr. 2021 Jan;45(1):136-145
pubmed: 32291773
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Crit Care. 2007;11(1):R11
pubmed: 17254336
J Intensive Care. 2020 Nov 23;8(1):87
pubmed: 33292655
Clin Nutr. 2021 Mar;40(3):1338-1347
pubmed: 32919818
Acta Neurol Scand. 2008 Sep;118(3):175-81
pubmed: 18355395
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):147-157
pubmed: 21475702
J Crit Care. 2018 Oct;47:324-330
pubmed: 30224027
Crit Care Med. 2005 Apr;33(4):711-5
pubmed: 15818093
Intensive Care Med. 2001 Apr;27(4):686-93
pubmed: 11398694
Crit Care. 2020 Nov 4;24(1):637
pubmed: 33148301
Intensive Care Med. 2018 Feb;44(2):263-264
pubmed: 29110031
Crit Care. 2011;15(1):R43
pubmed: 21276225
Intensive Care Med. 2010 Jan;36(1):66-74
pubmed: 19760204
Crit Care Med. 2009 Dec;37(12):3047-53
pubmed: 19770751
BMJ. 2013 Apr 24;346:f2304
pubmed: 23616031
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Intensive Care Med. 2005 Jan;31(1):157-61
pubmed: 15580474
Acta Anaesthesiol Scand. 2009 Jul;53(6):717-23
pubmed: 19388901
J Crit Care. 2015 Oct;30(5):1151.e9-14
pubmed: 26211979
Crit Care Med. 2001 Dec;29(12):2281-6
pubmed: 11801825
Lancet Neurol. 2011 Oct;10(10):931-41
pubmed: 21939902
PLoS One. 2019 Jun 13;14(6):e0216991
pubmed: 31194755
J Crit Care. 2018 Apr;44:87-94
pubmed: 29078131
BMC Anesthesiol. 2016 Nov 29;16(1):119
pubmed: 27894277
Ann Intensive Care. 2017 Oct 6;7(1):104
pubmed: 28986861
Crit Care Med. 2005 Feb;33(2):349-54
pubmed: 15699838
Intensive Care Med. 2001 Aug;27(8):1288-96
pubmed: 11511941
Clin Nutr ESPEN. 2021 Jun;43:408-414
pubmed: 34024548
Intensive Care Med. 2006 Feb;32(2):251-259
pubmed: 16468072
Shock. 2019 Mar;51(3):312-320
pubmed: 29757913
J Neurol. 2005 Mar;252(3):343-51
pubmed: 15791390
J Intensive Care. 2019 Dec 16;7:61
pubmed: 31890223
Clin Nutr. 2021 Mar;40(3):796-803
pubmed: 32800385
J Neurol Sci. 2015 Oct 15;357(1-2):276-81
pubmed: 26276515
Neth J Med. 2000 Jun;56(6):211-4
pubmed: 10821976
Intensive Care Med. 2019 Dec;45(12):1718-1731
pubmed: 31531715
J Intensive Care. 2018 Dec 12;6:81
pubmed: 30564367
Thorax. 2009 May;64(5):418-23
pubmed: 19158125
Crit Care. 2022 Aug 6;26(1):240
pubmed: 35933433
Chest. 2020 Jul;158(1):183-194
pubmed: 32247714
J Crit Care. 2020 Apr;56:125-131
pubmed: 31896446
Sci Rep. 2021 Sep 14;11(1):18280
pubmed: 34521934
J Hum Nutr Diet. 2017 Apr;30(2):227-235
pubmed: 27477516